×

Ablynx shares hit one-year high after Merck deal

BRUSSELS, Oct 2 (Reuters) - Shares in Ablynx hit a new one-year high after the Belgian drug developer announces it is entering into a potentially lucrative partnership with Merck & Co .

The shares rise as much as 4.1 percent in early trading to 4.80 euros.

(Reporting by Philip Blenkinsop)

Keywords: ABLYNX MERCK/SHARES